Cannabidiol (CBD) has quickly surfaced as one of the most versatile and effective medical treatments around. From simple ailments such as pain and inflammation to severe conditions such as diabetes and epilepsy, CBD has proven to be effective at managing a variety of disorders. Despite the plethora of anecdotal evidence on the efficacy of CBD, there has been limited scientific research on the matter, and due to this, medical professionals have been slow to recommend the product to their patients.
Amber Nelson, a mother from Cedar Rapids, Iowa, has been struggling to find help for her autistic son. She says that they have tried alternative treatments for the young boy, Dominic, but he is highly aggressive and has a tough time with transition. She and other Iowa parents have been struggling to find local doctors who approve of medical CBD. Finding help for Dominic has not been easy, she says. She’s even tried a patch of medication, and some doctors also recommended…
About CBDWire
CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.
To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.CBDWire.com
Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer
Do you have a questions or are you interested in working with CNW? Ask Our Editor
CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com